Vosevi (sofosbuvir / velpatasvir / voxilaprevir) Drug Interactions
A total of 137 drugs are known to interact with Vosevi (sofosbuvir / velpatasvir / voxilaprevir).
- 40 major drug interactions
- 93 moderate drug interactions
- 4 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Vosevi (sofosbuvir / velpatasvir / voxilaprevir) and the medicines listed below.
- Aldurazyme (laronidase)
- Baraclude (entecavir)
- Daklinza (daclatasvir)
- Elaprase (idursulfase)
- Kalydeco (ivacaftor)
- Lasix (furosemide)
- levofloxacin
- Librium (chlordiazepoxide)
- Mavyret (glecaprevir / pibrentasvir)
- Moderiba (ribavirin)
- NovoSeven RT (coagulation factor viia)
- omeprazole
- Placidyl (ethchlorvynol)
- Prograf (tacrolimus)
- Pulmozyme (dornase alfa)
- ribavirin
- ribavirin
- rifampin
- Sandostatin LAR Depot (octreotide)
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Victrelis (boceprevir)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viramune XR (nevirapine)
Vosevi (sofosbuvir / velpatasvir / voxilaprevir) alcohol/food interactions
There is 1 alcohol/food interaction with Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
Vosevi (sofosbuvir / velpatasvir / voxilaprevir) disease interactions
There are 4 disease interactions with Vosevi (sofosbuvir / velpatasvir / voxilaprevir) which include:
More about Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Pricing & Coupons
- En Español
- Drug class: antiviral combinations
- FDA Alerts (1)
- FDA Approval History
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
